Back to mobile site

OncoCyte (BTX) Adds Andrew Last as Director

December 23, 2015 8:16 AM EST Send to a Friend
OncoCyte Corporation (“OncoCyte”), a company focused on non-invasive cancer diagnostics, announced the appointment of Dr. Andrew J. Last as an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login